In more than half of human cancers, mutations are located in the DBD portion [9,10,11]; this can strongly alter the capability of p53 to perform its tumor suppressive functions and sometimes leads p53 to acquire new functions (gain-of-function, GOF), including transcriptional activation of different genes [12]. The gene discussed is TP53; the disease is neoplasm.